Haralambos P. Gavras
#115,014
Most Influential Person Now
Haralambos P. Gavras's AcademicInfluence.com Rankings
Haralambos P. Gavrasphilosophy Degrees
Philosophy
#4966
World Rank
#7655
Historical Rank
Logic
#2318
World Rank
#3287
Historical Rank
Haralambos P. Gavrasbiology Degrees
Biology
#6601
World Rank
#9353
Historical Rank
Genetics
#619
World Rank
#702
Historical Rank
Download Badge
Philosophy Biology
Haralambos P. Gavras's Degrees
- Doctorate Medicine Harvard University
Why Is Haralambos P. Gavras Influential?
(Suggest an Edit or Addition)Haralambos P. Gavras's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Evidence for a Gene Influencing Blood Pressure on Chromosome 17: Genome Scan Linkage Results for Longitudinal Blood Pressure Phenotypes in Subjects From the Framingham Heart Study (2000) (620)
- Antihypertensive effect of the oral angiotensin converting-enzyme inhibitor SQ 14225 in man. (1978) (613)
- Independence and reproducibility across microarray platforms (2005) (452)
- Oral angiotensin-converting enzyme inhibitor in long-term treatment of hypertensive patients. (1979) (374)
- The A2B adenosine receptor protects against inflammation and excessive vascular adhesion. (2006) (356)
- A SPECIFIC ORALLY ACTIVE INHIBITOR OF ANGIOTENSIN-CONVERTING ENZYME IN MAN (1977) (330)
- An angiotensin converting-enzyme inhibitor to identify and treat vasoconstrictor and volume factors in hypertensive patients. (1974) (324)
- Insulin infusion in conscious dogs. Effects on systemic and coronary hemodynamics, regional blood flows, and plasma catecholamines. (1982) (298)
- Angiotensin-Sodium Interaction in Blood Pressure Maintenance of Renal Hypertensive and Normotensive Rats (1973) (285)
- Antihypertensive action of propranolol. Specific antirenin responses in high and normal renin forms of essential, renal, renovascular and malignant hypertension. (1973) (264)
- Antihypertensive Therapy with MK 4211: Angiotensin II‐Renin Relationships to Evaluate Efficacy of Converting Enzyme Blockade (1982) (261)
- Angiotensin Converting Enzyme Inhibition in Patients with Congestive Heart Failure (1978) (252)
- Angiotensin-II blockade in man by sar1-ala8-angiotensin II for understanding and treatment of high blood-pressure. (1973) (242)
- Muscle glycogenolysis during exercise: dual control by epinephrine and contractions. (1982) (226)
- Concordance of murine quantitative trait loci for salt-induced hypertension with rat and human loci. (2001) (217)
- Mineralocorticoid-induced hypertension in patients with orthostatic hypotension. (1979) (214)
- Malignant Hypertension Resulting from Deoxycorticosterone Acetate and Salt Excess: ROLE OF RENIN AND SODIUM IN VASCULAR CHANGES (1975) (211)
- Contribution of vasopressin to vasoconstriction in patients with congestive heart failure: comparison with the renin-angiotensin system and the sympathetic nervous system. (1986) (207)
- Volume factor in low and normal renin essential hypertension. Treatment with either spironolactone or chlorthalidone. (1973) (191)
- ANTIHYPERTENSIVE EFFECT OF THE NEW ORAL ANGIOTENSIN CONVERTING ENZYME INHIBITOR "MK-421". (1981) (190)
- Acute Regional Circulatory and Renal Hemodynamic Effects of Converting‐enzyme Inhibition in Patients with Congestive Heart Failure (1981) (188)
- Acute renal failure, tubular necrosis, and myocardial infarction induced in the rabbit by intravenous angiotensin II. (1971) (177)
- Models of experimental hypertension in mice. (1996) (174)
- IMPROVEMENT OF CHRONIC CONGESTIVE HEART-FAILURE BY ORAL CAPTOPRIL (1979) (172)
- Three new long‐acting converting‐enzyme inhibitors: Relationship between plasma converting‐enzyme activity and response to angiotensin I (1981) (157)
- Renal revascularization in the azotemic hypertensive patient resistant to therapy. (1984) (154)
- Angiotensin- and norepinephrine-induced myocardial lesions: experimental and clinical studies in rabbits and man. (1975) (147)
- Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysine analogue on the components of the renin system in healthy subjects. (1981) (141)
- A cooperative multicenter study of captopril in congestive heart failure: hemodynamic effects and long-term response. (1985) (140)
- Discrepancy Between Antihypertensive Effect and Angiotensin Converting Enzyme Inhibition by Captopril (1980) (139)
- Reciprocation of renin dependency with sodium volume dependency in renal hypertension. (1975) (125)
- Vasodepressor role of endogenous bradykinin assessed by a bradykinin antagonist. (1986) (124)
- Vasoactive Potential of the B1 Bradykinin Receptor in Normotension and Hypertension (2001) (122)
- Reciprocal relation between renin dependency and sodium dependency in essential hypertension. (1976) (121)
- Role of the α2B-Adrenergic Receptor in the Development of Salt-Induced Hypertension (1999) (117)
- Role of vasopressin in essential hypertension: Racial differences (1997) (106)
- Angiotensin inhibition in severe heart failure: acute central and limb hemodynamic effects of captopril with observations on sustained oral therapy. (1981) (106)
- Role of the B2 Receptor of Bradykinin in Insulin Sensitivity (2001) (97)
- Microangiopathic haemolytic anaemia and the pathogenesis of malignant hypertension. (1969) (97)
- Nonarrhythmogenicity of diuretic-induced hypokalemia: its evidence in patients with uncomplicated hypertension (1984) (93)
- Interaction of the Sympathetic Nervous System with Vasopressin and Renin in the Maintenance of Blood Pressure (1982) (93)
- Evidence for linkage between essential hypertension and a putative locus on human chromosome 17. (1999) (92)
- Suppressing sympathetic activation in congestive heart failure. A new therapeutic strategy. (1995) (87)
- A2b Adenosine Receptor Regulates Hyperlipidemia and Atherosclerosis (2012) (85)
- A role for the A3 adenosine receptor in determining tissue levels of cAMP and blood pressure: studies in knock-out mice. (2000) (84)
- Sympathetic overactivity in hypertension and cardiovascular disease. (2014) (84)
- Angiotensin II as a cardiovascular risk factor (2002) (84)
- The renin axis and vasoconstriction volume analysis for understanding and treating renovascular and renal hypertension. (1975) (83)
- Renin-angiotensin system inhibition in conscious sodium-depleted dogs. Effects on systemic and coronary hemodynamics. (1978) (82)
- Cardiac transcriptional response to acute and chronic angiotensin II treatments. (2004) (81)
- Association of NEDD4L Ubiquitin Ligase With Essential Hypertension (2005) (81)
- Angiotensin Converting Enzyme Inhibitors Properties and Side Effects (1988) (81)
- Role of vasopressin, catecholamines, and plasma volume in hypertonic saline-induced hypertension. (1981) (79)
- Renin‐Angiotensin System Inhibition in Acute Myocardial Infarction in Dogs Effects on Systemic Hemodynamics, Myocardial Blood Flow, Segmental Myocardial Function and Infarct Size (1982) (78)
- Sympathoinhibitory Function of the α2A-Adrenergic Receptor Subtype (1999) (76)
- INNAPPROPRIATE RENIN SECRETION UNMASKED BY CAPTOPRIL (SQ 14 225) IN HYPERTENSION OF CHRONIC RENAL FAILURE (1978) (73)
- Clinical Use of an Orally Acting Converting Enzyme Inhibitor: Captopril (1980) (72)
- Localization of α2A- and α2B-Adrenergic Receptor Subtypes in Brain (1996) (72)
- The α2-adrenergic receptors in hypertension and heart failure: experimental and clinical studies (2001) (70)
- Congestive heart failure in normotensive man. Haemodynamics, renin, and angiotensin II blockade. (1978) (68)
- Angiotensin II inhibition. Treatment of congestive cardiac failure in a high-renin hypertension. (1977) (67)
- Mitochondrial genome mutations in hypertensive individuals. (2004) (65)
- Effect of furosemide on antibiotic-induced renal damage in rats. (1972) (65)
- Diverse tissue expression of rat alpha 2-adrenergic receptor genes. (1993) (64)
- Modulation of Angiotensin II–Mediated Cardiac Remodeling by the MEF2A Target Gene Xirp2 (2010) (64)
- Central and Peripheral Hemodynamic Effects of Angiotensin Inhibition in Patients with Refractory Congestive Heart Failure (1980) (62)
- How does salt raise blood pressure? A hypothesis. (1986) (62)
- Peptidyl dipeptidase in rabbit brain microvessels. (1978) (62)
- Regulation of Plasma Endothelin by Salt in Salt-Sensitive Hypertension (2001) (61)
- Pleiotropic effects of statins may improve outcomes in atherosclerotic renovascular disease. (2008) (60)
- Is elevated plasma renin activity of prognostic importance in progressive systemic sclerosis? (1977) (59)
- Corcoran Lecture. Angiotensin-converting enzyme inhibition and the heart. (1994) (58)
- Effects of a specific inhibitor of the vascular action of vasopressin in humans. (1984) (58)
- Polymorphisms in the Promoter Region of Catalase Gene and Essential Hypertension (2005) (57)
- Conditioning effects of chronic infusions of dobutamine. Comparison with exercise training. (1979) (57)
- Genetic analysis of blood pressure in C3H/HeJ and SWR/J mice. (2004) (56)
- Role of angiotensin and its inhibition in hypertension, ischemic heart disease, and heart failure. (2001) (56)
- Role of bradykinin in insulin sensitivity and blood pressure regulation during hyperinsulinemia. (1995) (56)
- Cardioprotective properties of bradykinin: role of the B2 receptor (2010) (55)
- Role of the postsynaptic alpha(2)-adrenergic receptor subtypes in catecholamine-induced vasoconstriction. (2000) (55)
- Hypertensive effect of a bradykinin antagonist in normotensive rats. (1986) (54)
- Fatal pancytopenia associated with the use of captopril. (1981) (54)
- Maternal component in the familial aggregation of hypertension (2001) (52)
- Angiotensin-Converting Enzyme Inhibition After Experimental Myocardial Infarct: Role of the Kinin B1 and B2 Receptors (2008) (52)
- The effect of angiotensin converting enzyme inhibition of coronary blood flow and hemodynamics in patients without coronary artery disease. (1982) (52)
- Renin-angiotensin system inhibition in conscious dogs during acute hypoxemia. Effects on systemic hemodynamics, regional blood flows, and tissue metabolism. (1978) (52)
- Regulation of Renin Gene Expression in Hypertensive Rats (1988) (52)
- α2 Adrenergic Receptor Subtypes Expressed in Chinese Hamster Ovary Cells Activate Differentially Mitogen-activated Protein Kinase by a p21ras Independent Pathway (*) (1995) (51)
- Effects of a vasopressin antagonist with combined antipressor and antiantidiuretic activities in rats with left ventricular dysfunction. (1990) (50)
- Specific inhibition of the renin-angiotensin system: A key to understanding blood pressure regulation. (1974) (50)
- Salt-induced hypertension: the interactive role of vasopressin and of the sympathetic nervous system. (1989) (50)
- Autosomal dominant orthostatic hypotensive disorder maps to chromosome 18q. (1998) (50)
- Role of bradykinin B1 and B2 receptors in normal blood pressure regulation. (2006) (49)
- Effects of ANG II on bradykinin receptor gene expression in cardiomyocytes and vascular smooth muscle cells. (2001) (48)
- Cloning and expression of a rat brain alpha 2B-adrenergic receptor. (1991) (48)
- Cardioprotective effects of a selective B(2) receptor agonist of bradykinin post-acute myocardial infarct. (2010) (48)
- Norepinephrine applied in the paraventricular hypothalamic nucleus stimulates vasopressin release (1986) (47)
- Issues in hypertension: drug tolerability and special populations. (2000) (47)
- Sodium-induced elevation of blood pressure in the anephric state. (1980) (47)
- Coronary hemodynamic effects of angiotensin inhibition by captopril and teprotide in patients with congestive heart failure. (1982) (46)
- Association between hypervolemia and ventricular hypertrophy in hemodialysis patients. (2004) (46)
- Effects of eprosartan versus enalapril in hypertensive patients on the renin-angiotensin-aldosterone system and safety parameters: results from a 26-week, double-blind, multicentre study. Eprosartan Multinational Study Group. (1999) (46)
- Cardioprotective potential of angiotensin-converting enzyme inhibitors. (1991) (46)
- Angiotensin blockade for hypertension: a promise fulfilled (2002) (45)
- Identification of a polymorphic glutamic acid stretch in the alpha2B-adrenergic receptor and lack of linkage with essential hypertension. (1999) (44)
- Role of alpha(2)-adrenergic receptor subtypes in the acute hypertensive response to hypertonic saline infusion in anephric mice. (2000) (44)
- A novel class of tests for the detection of mitochondrial DNA-mutation involvement in diseases. (2003) (43)
- Abnormal glucoregulation during exercise in type II (non-insulin-dependent) diabetes. (1987) (43)
- Pressor Hormones in Elderly Hypertensive Persons Racial Differences (1990) (43)
- The angiotensin II type 1 receptor blocker losartan in clinical practice: a review. (1996) (42)
- Inhibition of nitric oxide, bradykinin, and prostaglandins in normal rats. (1992) (42)
- α-Adrenoceptor agonists applied in the area of the nucleus tractus solitarii in the rat: effect of anesthesia on cardiovascular responses (1985) (41)
- Genetic Variants of WNK4 in Whites and African Americans With Hypertension (2003) (40)
- Renin and angiotensin II receptor gene expression in kidneys of renal hypertensive rats. (1995) (38)
- Association of polymorphisms in the promoter region of the PNMT gene with essential hypertension in African Americans but not in whites. (2003) (38)
- Norepinephrine and Renin Activity in Chronic Renal Failure: Evidence for Interacting Roles in Hemodialysis Hypertension (1981) (37)
- Central and peripheral indices of sympathetic activity after blood pressure lowering with enalapril (MK-421) or hydralazine in normotensive rats. (1984) (37)
- Effects of Antisense Oligodeoxynucleotide Targeting of the &agr;2B-Adrenergic Receptor Messenger RNA in the Central Nervous System (2001) (37)
- Genetic predisposition to stroke in relatives of hypertensives. (2000) (36)
- Modern strategies to prevent coronary sequelae and stroke in hypertensive patients differ from the JNC V Consensus Guidelines. (1994) (36)
- Does vasopressin sustain blood pressure of normally hydrated healthy volunteers? (1984) (36)
- The Opposing Effects of Chronic Angiotensin‐Converting Enzyme Blockade by Captopril on the Responses to Exogenous Angiotensin II and Vasopressin vs. Norepinephrine in Rats (1981) (36)
- Dobutamine Infusion in Conscious Dogs with and without Acute Myocardial Infarction (1981) (36)
- Angiotensin converting enzyme inhibition and its impact on cardiovascular disease. (1990) (36)
- Converting enzyme inhibition in hypertensive emergencies. (1979) (36)
- Microangiopathic Hemolytic Anemia and the Development of the Malignant Phase of Hypertension (1971) (36)
- A new highly potent antagonist of bradykinin (1990) (35)
- Angiotensin II blockade in normal man: interaction of renin and sodium in maintaining blood pressure. (1977) (35)
- Blood viscosity, plasma proteins, and Raynaud syndrome. (1975) (34)
- α1-Adrenergic Plus Angiotensin Receptor Blockade Reduces Atherosclerosis in Apolipoprotein E–Deficient Mice (1998) (34)
- Role of α2-adrenergic receptors in hypertension* (2001) (34)
- Age-related changes of bradykinin B1 and B2 receptors in rat heart. (2005) (34)
- Sequence variation of bradykinin receptors B1 and B2 and association with hypertension (2004) (34)
- Enalaprilat in Hypertensive Emergencies (1986) (34)
- Localization of alpha 2A- and alpha 2B-adrenergic receptor subtypes in brain. (1996) (34)
- Converting Enzyme Inhibition During Chronic Angiotensin II Infusion in Rats: Evidence Against a Nonangiotensin Mechanism (1981) (33)
- Mechanisms Mediating the Vasoactive Effects of the B1 Receptors of Bradykinin (2003) (33)
- Reversal of experimental delayed cerebral vasospasm by angiotensin-converting enzyme inhibition. (1981) (33)
- Role of the alpha2B-adrenergic receptor in the development of salt-induced hypertension. (1999) (32)
- Changes of renin in individual glomeruli in response to variations of sodium intake in the rabbit. (1970) (32)
- Prior exercise potentiates the thermic effect of a carbohydrate load. (1986) (32)
- Effect of angiotensin converting enzyme inhibition on blood pressure, plasma renin activity and plasma aldosterone in essential hypertension. (1978) (32)
- Mechanism of blood pressure reduction by teprotide (SQ 20881) in rats. (1978) (31)
- Captopril and enalapril. (1983) (31)
- Prediction of sustained antihypertensive efficacy of chronic captopril therapy: relationships to immediate blood pressure response and control plasma renin activity. (1982) (31)
- The alpha2 -adrenergic receptors in hypertension and heart failure: experimental and clinical studies. (2001) (31)
- Cell Signaling, Internalization, and Nuclear Localization of the Angiotensin Converting Enzyme in Smooth Muscle and Endothelial Cells* (2009) (30)
- Safety and Efficacy of Chronic Therapy with Captopril in Hypertensive Patients: An Update (1981) (30)
- The antiarrhythmic potential of angiotensin II antagonism: experience with losartan. (2000) (30)
- Renin and aldosterone and the pathogenesis of hypertensive vascular damage. (1974) (29)
- Is the renin system necessary? (1980) (29)
- Effects of bradykinin and prostaglandin inhibition on systemic and regional hemodynamics in conscious normotensive rats. (1991) (29)
- Effects of tyrosine infusion in normotensive and hypertensive rats. (1980) (29)
- Effect of Aging on Vasopressin, Catecholamines, and Alpha2‐Adrenergic Receptors (1990) (28)
- The use of angiotensin-converting enzyme inhibitor in the diagnosis and treatment of hypertension. (1975) (28)
- Sequential Elimination of Pressor Mechanisms in Severe Hypertension in Humans (1986) (28)
- Vasopressin in Salt‐Induced Hypertension of Experimental Renal Insufficiency (1982) (28)
- Uncontrollable hypertension in patients on hemodialysis: long-term treatment with captopril and salt subtraction. (1981) (28)
- Vascular and Sympathoadrenal Responses to Bradykinin and a Bradykinin Analogue (1988) (28)
- Expression of alpha2-adrenergic receptors in normal and atherosclerotic rabbit aorta. (1998) (27)
- Sodium chloride-induced partial inhibition in vivo of alpha 2-adrenoceptor agonist function. (1985) (27)
- Blood Pressure Response to Central and /or Peripheral Inhibition of Phenylethanolamine N‐Methyltransferase in Normotensive and Hypertensive Rats (1981) (27)
- Angiotensin-converting enzyme regulates bradykinin receptor gene expression. (2005) (27)
- Biliary excretion of 35 S-labelled propylthiouracil, methimazole and carbimazole in untreated and pentobarbitone pretreated rats. (1972) (26)
- Acute Renovascular Hypertension in Conscious Dogs: Interaction of the Renin‐Angiotensin System and Sympathetic Nervous System in Systemic Hemodynamics and Regional Blood Flow Responses (1980) (26)
- Comparison of spirapril, isradipine, or combination in hypertensive patients with left ventricular hypertrophy: effects on LVH regression and arrhythmogenic propensity. (1998) (26)
- Hypertension and unilateral parenchymal renal disease. Evidence for abnormal vasoconstriction-volume interaction. (1975) (26)
- The place of angiotensin-converting enzyme inhibition in the treatment of cardiovascular diseases. (1988) (25)
- The Role of Vasopressin in Blood Pressure Maintenance in Diabetic Orthostatic Hypotension (1988) (25)
- Antihypertensive effectiveness of the nifedipine gastrointestinal therapeutic system. (1987) (25)
- Role of substance P in blood pressure regulation in salt-dependent experimental hypertension. (1997) (25)
- Central α2B-adrenergic receptor antisense in plasmid vector prolongs reversal of salt-dependent hypertension (2003) (25)
- Combined sympathetic suppression and angiotensin-converting enzyme inhibition in congestive heart failure. (1997) (25)
- Enhancement by diuretics of the antihypertensive action of long-term angiotensin converting enzyme blockade. (1980) (24)
- Abnormalities of coagulation and the development of malignant phase hypertension. (1975) (24)
- RHC 3659: a new orally active angiotensin converting enzyme inhibitor in normal volunteers. (1981) (24)
- Renin and Acute Circulatory Renal Failure in the Rabbit (1972) (24)
- ‘Volume-expanded’ hypertension: the effect of fluid overload and the role of the sympathetic nervous system in salt-dependent hypertension (2012) (24)
- Alpha and beta adrenoceptor blockade in normotensive and deoxycorticosterone (DOC)-hypertensive rats; plasma vasopressin and vasopressin pressor effect. (1983) (23)
- Impact of Captopril on Hemodynamic and Hormonal Effects of Nitroprusside (1985) (23)
- A multicenter trial of enalapril in the treatment of essential hypertension. (1986) (23)
- Effects of chronic administration of a vasopressin antagonist with combined antivasopressor and antiantidiuretic activities in rats with left ventricular dysfunction. (1991) (22)
- Long-term treatment of hypertension in man by an orally active angiotensin-converting enzyme inhibitor. (1978) (21)
- Comparison of systemic and regional hemodynamic effects of a diuretic, an angiotensin II receptor antagonist, and an angiotensin-converting enzyme inhibitor in conscious renovascular hypertensive rats. (1992) (21)
- A Comparative Study of the Effects of Oxprenolol Versus Propranolol in Essential Hypertension (1979) (21)
- Genetic epidemiology of essential hypertension (1999) (21)
- A novel bradykinin antagonist with improved properties (1991) (21)
- Effect of ramipril on cardiovascular events in high-risk patients. (2000) (21)
- Role of bradykinin in hypertension and the antihypertensive effect of angiotensin-converting enzyme inhibitors. (1988) (21)
- Role of Reactive Hyperreninemia in Blood Pressure Changes Induced by Sodium Depletion in Patients with Refractory Hypertension (1981) (21)
- The conversion of angiotensin I to angiotensin II by rabbit glomeruli. (1972) (20)
- Hypertension and age: clinical and biochemical correlates. (1982) (20)
- Role of vasoconstrictor systems in experimental glucocorticoid-hypertension in rats. (1983) (20)
- Contribution of vasopressin to orthostatic blood pressure maintenance in essential hypertension. (1993) (20)
- The nephrotoxicity of cephaloridine. (1970) (20)
- Hypertensice response to saline microinjection in the area of the nucleus tractus solitarii of the rat (1985) (20)
- Acute effect of clonidine on left ventricular pressure-volume relation in hypertensive patients with diastolic heart dysfunction (2001) (20)
- Evidence for a sodium-induced activation of central neurogenic mechanisms in one-kidney, one-clip renal hypertensive rats. (1982) (20)
- Arterial compliance changes in diabetic normotensive patients after angiotensin-converting enzyme inhibition therapy (2005) (20)
- Interrelations of renin, angiotensin II, and sodium in hypertension and renal failure. (1976) (19)
- Pressor systems in hypertension and congestive heart failure. Role of vasopressin. (1990) (19)
- Pilot Study of the Effects of the Angiotensin‐Converting Enzyme Inhibitor CI‐906 on Patients with Essential Hypertension (1984) (19)
- Promoter region of the human alpha 2A adrenergic receptor gene. (1992) (19)
- Central alpha-adrenoceptors during the development of hypertension in rats on high and low salt intake. (1986) (18)
- Systemic and regional hemodynamic effects of endogenous vasopressin stimulation in rats. (1982) (18)
- Escape from mineralocorticoid excess: the role of angiotensin II. (1982) (18)
- Arterial compliance changes in diabetic normotensive patients after angiotensin-converting enzyme inhibition therapy. (2003) (18)
- A novel gene (Cmya3) induced in the heart by angiotensin II-dependent but not salt-dependent hypertension in mice. (2005) (18)
- Inappropriate attribution: the "Lazy Author Syndrome". (2002) (18)
- Sympathoinhibitory function of the alpha(2A)-adrenergic receptor subtype. (1999) (18)
- Role of vasopressin in clinical hypertension and congestive cardiac failure: interaction with the sympathetic nervous system. (1991) (18)
- Renin and Renal Function (1972) (18)
- Need for beta-blockade in hypertension reduced with long-term minoxidil. (1978) (17)
- Effect of a New Beta‐Adrenergic Blocker, L‐Bunolol, on Blood Pressure and on the Renin—Aldosterone System (1977) (17)
- Effects of a Novel Renin Inhibitor in Patients with Essential Hypertension (1990) (17)
- Reversal of experimental acute cerebral vasospasm by angiotensin converting enzyme inhibition. (1982) (17)
- A negative regulatory element in the promoter region of the rat alpha 2A-adrenergic receptor gene overlaps an SP1 consensus binding site. (1995) (17)
- The Adrenergic System and the Release and Pressor Action of Vasopressin (1986) (17)
- Effects of the new oral angiotensin converting enzyme inhibitor MK-421 in human hypertension. (1982) (17)
- Efficacy and tolerability of enalapril monotherapy in mild-to-moderate hypertension in older patients compared to younger patients. (1987) (17)
- Chronic sympathetic suppression in the treatment of chronic congestive heart failure. (1998) (17)
- Possible mechanisms of sodium-dependent hypertension: volume expansion or vasoconstriction? (1982) (16)
- Chronic hypertension increases tyrosine transport across the blood-brain barrier in the rat. (1981) (16)
- Vascular Damage in Hypertension (1975) (16)
- Atrial natriuretic peptide inhibits the agonist-induced increase in extent of myosin light chain phosphorylation in aortic smooth muscle. (1988) (16)
- The contribution of the renin-angiotensin system to limb vasoregulation in patients with heart failure: observations during orthostasis and alpha-adrenergic blockade. (1985) (16)
- Effect of renin-angiotensin system on limb circulation in normal subjects. (1984) (16)
- Augmentation of coronary blood flow by ACE inhibition: role of angiotensin and bradykinin. (1995) (16)
- Effect of Nadolol in Treatment of Hypertension (1979) (16)
- Metabolic effects of angiotensin-converting enzyme inhibition: the role of bradykinin (2002) (16)
- Mitochondrial DNA mutations in patients with orthostatic hypotension. (1999) (15)
- Historical evolution of angiotensin II receptor blockers: therapeutic advantages. (1999) (15)
- Role of alpha2-adrenergic receptors in hypertension. (2001) (15)
- Reninlike enzymatic activity in the cerebral microvessels of the rat. (1980) (14)
- Plasma angiotensin II, renin, renin-substrate and aldosterone concentrations in acute renal failure in man. (1975) (14)
- Clinical implications of renin in the hypertensive patient. (1975) (14)
- Salt-induced hypertension in chronic renal failure: evidence for a neurogenic mechanism. (1983) (14)
- Endothelin–aldosterone interaction and proteinuria in low-renin hypertension (2004) (14)
- Frequency of coronary artery disease in patients with renal artery stenosis without clinical manifestations of coronary insufficiency. (2006) (13)
- Letter: Hypotensive effect of angiotensin-converting-enzyme inhibitor SQ 20,881. (1974) (13)
- Are patients who develop angioedema with ACE inhibition at risk of the same problem with AT1 receptor blockers (2003) (13)
- Safety and Tolerability of Eprosartan (1999) (13)
- Hypertension and congestive heart failure: benefits of converting enzyme inhibition (captopril). (1983) (13)
- Orally active angiotensin-converting enzyme inhibitor (SO 14,225) as a treatment for essential hypertension. (1979) (13)
- Vascular Permeability Factor: Dissociation from the Angiotensin II Induced Pressor and Drinking Responses (1973) (13)
- Comparison in normal volunteers of three converting enzyme inhibitors: RHC 3659, MK 421 and captopril. (1982) (12)
- Attenuation of angiotensin II-induced hypertension and cardiac hypertrophy in transgenic mice overexpressing a type 1 receptor mutant. (2009) (12)
- Age and Race Determine Vasopressin Participation in Upright Blood Pressure Control in Essential Hypertension (1993) (12)
- Is 44-Hour Better than 24-Hour Ambulatory Blood Pressure Monitoring in Hemodialysis? (2006) (12)
- Vasopressin response to hyperosmotic stimulus: blood pressure effect in normal subjects and patients with impaired sympathetic system. (1984) (12)
- Blockade of platelet alpha2B-adrenergic receptors: a novel antiaggregant mechanism. (2013) (12)
- Hemodynamic and humoral correlates in essential hypertension: relationship between patterns of LVH and myocardial ischemia. (1997) (12)
- Effects of the oral angiotensin-converting enzyme inhibitor MK-421 in human hypertension. (1981) (12)
- Physiologic studies with saralasin in animals. (1979) (11)
- The A 2 b Adenosine Receptor Regulates Hyperlipidemia and Atherosclerosis (2011) (11)
- Clinical utility of angiotensin converting enzyme inhibitors in hypertension. (1986) (11)
- Update on the clinical pharmacology of candesartan cilexetil. (2000) (11)
- Angiotensin converting enzyme inhibitors. (1991) (11)
- Evidence for cell-specific regulation of transcription of the rat alpha2A-adrenergic receptor gene. (1996) (11)
- Alpha1-adrenergic plus angiotensin receptor blockade reduces atherosclerosis in apolipoprotein E-deficient mice. (1998) (11)
- Long-term inhibition of the central alpha(2B)-adrenergic receptor gene via recombinant AAV-delivered antisense in hypertensive rats. (2006) (11)
- Differential gene expression of bradykinin receptors 1 and 2 in peripheral monocytes from patients with essential hypertension (2014) (10)
- On the JNC V report. A different point of view. (1994) (10)
- Evidence for bradykinin potentiation by angiotensin congeners in conscious rats. (1981) (10)
- Angiotensin II blockade in normal man and patients with essential hypertension. Blood pressure effects depending on renin and sodium balance. (1976) (10)
- Captopril in the treatment of hypertension. (1981) (10)
- Genes and genetic variations involved in the development of hypertension: focusing on a Greek patient cohort. (2014) (10)
- Role of Angiotensin and its Inhibition in Hypertension, Ischemic Heart Disease and Heart Failure (2006) (10)
- High level of expression of functional human platelet alpha 2-adrenergic receptors in a stable mouse C127 cell line. (1990) (10)
- Clinical Utility of Long‐Term Enalapril/Diltiazem ER in Stage 3–4 Essential Hypertension (1997) (9)
- Hypertension in a patient with hypercalcemia: captopril and verapamil. (1982) (9)
- Serial analysis of gene expression in mouse kidney following angiotensin II administration. (2003) (9)
- Central catecholamines and alpha-adrenoceptors in acute hypertension induced by intracerebroventricular hypertonic saline. (1987) (9)
- Are patients who develop angioedema with ACE inhibition at risk of the same problem with AT1 receptor blockers? (2003) (9)
- Anti-hormones and blood pressure: bradykinin antagonists in blood pressure regulation. (1988) (9)
- Acute Circulatory Renal Failure: A Probable Manifestation of Excess Renin Release (1972) (9)
- Novel targets of ANG II regulation in mouse heart identified by serial analysis of gene expression. (2004) (9)
- Study of Hypertension in Spontaneous Hypertensive Rats by Sequencing the Genomic DNA of Alpha 2B Receptors (2004) (9)
- Pathogenesis of Hypertension: A Review (2009) (9)
- Contribution of Bradykinin to Maintenance of Normal Blood Pressure (1987) (9)
- Expression of Multiple α2‐Adrenergic Receptor Messenger RNA Species in Rat Tissues (1990) (9)
- Central sympathetic stimulation produced by saline application into the nucleus tractus solitarii area of conscious rats (1988) (9)
- ACE inhibitors: a decade of clinical experience. (1993) (8)
- Effects of ACE inhibition on the heart. (1995) (8)
- Bradykinin Antagonism and Prostaglandins in Blood Pressure Regulation (1989) (8)
- Clinical hypertension and hypotension (1982) (8)
- Evidence for dopaminergic regulation of vasopressin release in the anephric rat. (1984) (8)
- Potent antiproliferative activity of bradykinin B2 receptor selective agonist FR-190997 and analogue structures thereof: A paradox resolved? (2020) (8)
- Converting enzyme inhibition during chronic angiotensin II infusion in rats: evidence against a non-angiotensin mechanism. (1980) (8)
- Use of saralasin as a diagnostic test in hypertension. Report of a Consensus Committee. (1982) (8)
- Calcium stimulates vasopressin release. (1986) (8)
- Effect of combination therapy with atenolol and the angiotensin-converting enzyme inhibitor benazepril. (1994) (8)
- Nifedipine in the Treatment of Essential Hypertension (1985) (8)
- Hypertension in transgenic mice with brain-selective overexpression of the alpha(2B)-adrenoceptor. (2009) (8)
- Pressor hormone profile during stress in hypertension: does vasopressin interfere with left ventricular hypertrophy? (1993) (7)
- Angiotensin-Converting Enzyme Inhibition After Experimental Myocardial Infarct Role of the Kinin B 1 and B 2 Receptors (2008) (7)
- Benefits and side effects of blood pressure lowering treatment: what was wrong with doxazosin in the ALLHAT? (2001) (7)
- Cardioprotective potential of angiotensin converting enzyme inhibitors. (1996) (7)
- Angiotensin-Converting Enzyme Inhibition and the Heart (2005) (7)
- Angiotensin II antagonists: clinical experience in the treatment of hypertension, prevention of cardiovascular outcomes and renal protection in diabetic nephropathy and proteinuria. (2006) (7)
- Effect of Pindolol on Blood Pressure, Plasma Renin Activity, and Catecholamines in Hypertensive Patients (1981) (6)
- The Renin-Angiotensin System and the Heart (1999) (6)
- Nonarrhythmogenicity of diuretic-induced hypokalemia. Its evidence in patients with uncomplicated hypertension. (1985) (6)
- Calcium antagonism abolishes the antipressor action of vasopressin (V1) receptor antagonism. (1997) (6)
- Systemic and regional hemodynamic effects of propranolol in intact and anephric rats. (1983) (6)
- Hemodynamic Effects of a Kinin Antagonist (1990) (6)
- Vasopressin in end-stage renal disease: relationship to salt, catecholamines and renin activity. (1987) (6)
- RATIONAL USE OF CAPTOPRIL (1979) (6)
- Double-blind, placebo-controlled trial of twice-daily nifedipine as a step-2 agent in mild essential hypertension. (1987) (6)
- Relationship of basal plasma noradrenaline to blood pressure, age, sex, plasma renin activity and plasma volume in essential hypertension. (1978) (6)
- Hypertension, vasoactive peptides and coagulation factors. (2004) (6)
- Leukopenia: idiopathic or drug-induced? (1982) (6)
- Drug therapy for hypertension. (1997) (6)
- Isradipine versus captopril in patients with essential hypertension. (1995) (6)
- Hypertension in the Aging Patient Implications for the Selection of Drug Therapy (1989) (6)
- The Antihypertensive Action of Methyldopa in Relation to Its Effect on the Renin—Aldosterone System (1977) (5)
- Sunday, 26 August 2012 (2012) (5)
- Evolution and hypertension: is the Renin system necessary? (2007) (5)
- The antihypertensive contribution of bradykinin as assessed by a specific bradykinin antagonist. (1987) (5)
- The role of ACE inhibition in heart failure (2001) (5)
- Renin-angiotensin and vasopressin in the development of salt-induced hypertension. (1988) (5)
- Renin inhibition with A-64662: effect on blood pressure and hormonal response in man. (1989) (5)
- Antihypertensive action of beta-adrenoceptor blockade and the renin-angiotensin system. (1979) (5)
- Hypertension in the elderly (1983) (5)
- The economics of therapeutic advances: the paradigm of sympathetic suppression in chronic heart failure. (1999) (5)
- The effect of rapid decreases of blood pressure by different mechanisms on coronary flow and flow reserve in normal coronary arteries. (2003) (5)
- Role of bradykinin B 1 and B 2 receptors in normal blood pressure regulation (2006) (5)
- Relationship of basal plasma norepinephrine to blood pressure, plasma renin activity, mineralocorticoids, and plasma volume in essential hypertension. (1978) (4)
- Effects of vasopressin V1-receptor blockade during acute and sustained hypovolemic hypotension. (1996) (4)
- Pressor Hormones in Elderly Hypertensive Persons (2017) (4)
- Acute cardiovascular effects of two central phenylethanolamine-N-methyl-transferase inhibitors in unanesthetized desoxycorticosterone-salt hypertensive rats. (1984) (4)
- Validation of in-vitro data by in-vivo evidence: the example of angiotensin (1-7). (2006) (4)
- Inhibition of the alpha(1D)-adrenergic receptor gene by RNA interference (RNAi) in rat vascular smooth muscle cells and its effects on other adrenergic receptors. (2007) (4)
- Role of vasopressin in 24-hour blood pressure regulation in diabetic patients with autonomic neuropathy. (2002) (4)
- Vasopressin Blood Pressure Dependency after α-Adrenoceptor Blockade in Normotensive and Mineralocorticoid-Salt Hypertensive Rats (1982) (4)
- Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysine analogue on the components of the renin system in healthy subjects. 1981. (2004) (4)
- Salt in hypertension: physiological and molecular aspects. (1998) (4)
- Relationships of Renin and Aldosterone to Antihypertensive Effects of Spironolactone and Propranolol (1978) (4)
- Pressor Mechanisms in Adriamycin‐Induced Nephropathy With Hypertension in Rats (1994) (4)
- Captopril and salt subtraction to treat "uncontrollable" hypertension in haemodialysis patients. (1979) (4)
- Extended Therapy with a Trimethoprim-Sulphonamide for the Treatment of Established Urinary Tract Infection (1971) (4)
- Hemodynamic response to vasopressin during V1-receptor antagonism in baroreflex-deficient subjects. (1995) (4)
- Angiotensin converting enzyme inhibition in essential hypertension (1977) (4)
- Interaction of the Sympathetic Nervous System with Vasopressin and Renin in the Maintenance of Blood Pressure in Rats (1982) (4)
- Dilevalol in severe hypertension. A multicenter trial of bolus intravenous dosing. (1989) (4)
- Gene expression of catecholaminergic receptors in the central nervous system of hypertensive rats. (1991) (4)
- Angiotensin-converting enzyme inhibitors in hypertension and congestive heart failure. (1990) (4)
- Cardiovascular effects of a specific nonpeptide antagonist of substance P (NK-1) receptor in DOCA-salt hypertension. (1995) (4)
- Regional blood flows and cardiac hemodynamics in renovascular and mineralocorticoid hypertensive rats. (1984) (4)
- Redistribution of regional blood flow after administration of saralasin in salt-depleted dogs. (1978) (3)
- Cardiovascular effects of dobutamine and converting enzyme inhibition in rats with diabetic ketoacidosis. (1985) (3)
- A new highly potent antagonist of bradykinin. (1990) (3)
- Long-range safety and protective benefits of angiotensin-converting enzyme inhibitors for hypertension. Do we need more clinical trials? (1993) (3)
- Synthesis and some pharmacological properties of three new bradykinin antagonists (1991) (3)
- Evaluation of enalapril combined with diltiazem ER in patients with stage 3-4 essential hypertension. (1998) (3)
- Oral milrinone in severe chronic heart failure. (1992) (3)
- NEW POTENT B2 BRADYKININ ANTAGONISTS ACYLATED WITH BULKY SUSBTITUENTS ON THEIR N-TERMINALS (1993) (3)
- Angiotensin II blockade in congestive heart failure. (1978) (3)
- The discovery of Captopril: reply (2004) (3)
- Pre- and Postsynaptic Effects of SKF64139, a Phenylethanolamine N‐Methyltransferase Inhibitor, in Conscious Normotensive Rats (1982) (3)
- Angiotensin II antagonism: a new avenue of hypertension management. (1997) (3)
- Modern approaches to initiating antihypertensive therapy. (1995) (3)
- The á2-adrenergic receptors in hypertension and heart failure: experimental and clinical studies (2001) (3)
- [Angiotensin II inhibitors for the diagnosis and treatment of hypertension]. (1976) (3)
- Position Paper: Angiotensin-Converting Enzyme Blockade as a Therapeutic Modality (1981) (2)
- Effect of arginine vasopressin on coronary and systemic hemodynamics in man. (1989) (2)
- Position Paper: Vasoconstriction and Volume Factors in Renovascular Hypertension (1981) (2)
- Systemic and coronary hemodynamic effects of reninangiotensin system inhibition in sodium-depleted dogs (1978) (2)
- The debate goes on--what is your choice? (2005) (2)
- The role of angiotensin converting enzyme inhibitors in the management of urgent hypertensive situations : a review (1992) (2)
- Intravenous dilevalol in the treatment of severe hypertension. (1989) (2)
- Cardiovascular responses in the diabetic rat. (1984) (2)
- Two highly effective V1/V2 antagonists of vasopressin containing novel thioacids at position 1 (1991) (2)
- Angiotensin converting enzyme inhibition: a new therapeutic modality. (1981) (2)
- Letter: Renin profiling in hypertension. (1976) (2)
- [Potentiation of the antihypertensive effect of captopril by diuretics (author's transl)]. (1979) (2)
- Angiotensin-converting enzyme regulates bradykinin receptor gene exression (2004) (2)
- Synthesis and some pharmacologic properties of five novel V1 or V1/V2 antagonists of AVP (1989) (2)
- Diverse Tissue Expression of Rat or 2-Adrenergic Receptor Genes (2005) (2)
- Hypertension, Vasopressors, and Susceptibility to Vascular Injury: Experimental and Clinical Studies (1981) (2)
- Acylation of the N-Terminus of B2 Bradykinin Antagonists with Bulky Substituents Dramatically Increases Potency (1992) (2)
- Determination of renin-dependency and sodium-dependency in the three renin sub-groups of essential hypertension. (1976) (2)
- Central plasmid antisense administration reduces blood pressure inhibiting alpha2B adrenoceptor gene expression in spontaneously hypertensive rats in vivo. (2006) (2)
- Captopril: an oral angiotension converting enzyme inhibitor active in man. (1980) (2)
- How Does Salt Raise Blood Pressure? (2005) (1)
- P-220: Comparison of diltiazem-SR vs amlodipine on resting and stimulated blood pressure, catecholamines and diastolic dysfunction in patients with mild to moderate essential hypertension (2001) (1)
- Renin-Angiotensin System Inhibition in Conscious Sodium-Depleted Dogs EFFECTS ON SYSTEMICANDCORONARYHEMODYNAMICS (1)
- Renal artery clipping attenuates the progression of adriamycin nephropathy. (1998) (1)
- The calcium channel antagonist controversy. (1998) (1)
- First Choice of Antihypertensive Therapy (2006) (1)
- Angiotensin-Converting Enzyme Inhibitors or Calcium Channel Blockers? (2012) (1)
- Treatment of hypertension in the elderly: a review (1991) (1)
- Blockade of platelet alpha2B-adrenergic receptors in patients with coronary artery disease: a novel antiaggregant mechanism (2013) (1)
- Special considerations in treating hypertension in the elderly. (1980) (1)
- Early experience with angiotensin II receptor antagonists and angiotensin-converting enzyme inhibitors. (2001) (1)
- [Chronic treatment of hypertension by an inhibitor of angiotensin converting enzyme]. (1978) (1)
- Comparative study of three parenteral inhibitors of the angiotensin converting enzyme. (1981) (1)
- Pathophysiological concepts of renovascular hypertension. (1976) (1)
- Microangiopathic haemolytic anaemia in malignant phase hypertension. (1973) (1)
- Effect of sodium on central alpha 2-adrenergic receptors. (1988) (1)
- Report on the fifth annual Laragh conference: Interaction of the angiotensin converting enzyme (ACE) with the renin-angiotensin system, the kinin system and beyond. (2005) (1)
- Progress in stroke prevention: Lessons from the latest trials (2004) (1)
- Adrenergic receptors in hypertension and heart failure. (2004) (1)
- [Renin and sodium in blood pressure regulation]. (1974) (1)
- Renal Damage in Rats (1972) (1)
- A free-ranging roundtable discussion on hypertension (2005) (1)
- The american journal of hypertension withdraws from its affiliation with the american society of hypertension. A report to our readers (2005) (1)
- Wednesday May 28, Ballroom C, 3:30 pm Update in Hypertension and Target Organ Damage: Prevention of myocardial damage in hypertension (1997) (1)
- The role of AII antagonists in hypertension : Focus on telmisartan (2000) (1)
- Targeted cDNA differential display (TcDD). (2006) (1)
- Comparative effects of two different angiotensin inhibitors in essential hypertension (1977) (1)
- Acute Effects of the New Angiotensin‐Converting Enzyme Inhibitor Cilazapril: A Pilot Study (1988) (1)
- Commentary 1 (0)
- ACKNOWLEDGMENTS (1987) (0)
- What is the Effect of Arginine Vasopressin on Coronary and Systemic Vascular Tone in Man (1989) (0)
- bradykinin antagonists and their use acylated. (1990) (0)
- Angiotensin-converting enzyme inhibitors: pathogenic and therapeutic implications for arterial hypertension. (1981) (0)
- Maternal Influence on the Inheritance of Hypertension (2000) (0)
- Synthesis and Some Pharmacological Properties of Three New Bradykinin Antagonists. (1991) (0)
- CLINICAL AND EXPERIMENTAL ASPECTS OF THE ANGIOTENSIN CONVERTING ENZYME IN BLOOD PRESSURE REGULATION (1983) (0)
- [PP.30.10] INCREASED ALPHA2B-ADRENERGIC RECEPTORS GENE EXPRESSION IN PLATELETS FROM PATIENTS WITH NOT ADEQUATELY CONTROLLED ESSENTIAL HYPERTENSION (2017) (0)
- The future of converting enzyme inhibitors as cardioprotective agents (1990) (0)
- COMMENTARY ON KOSTIS'S REPORT FROM SOLVD. QUESTIONS. AUTHOR'S REPLY (1996) (0)
- Synthesis and some pharmacological properties of new V1/V2 antagonists of arginine-vasopressin with structural changes at their N-terminals. (1992) (0)
- Congestive heart failure in normotensive man Haemodynanics , renin , and angiotensin II blockade GUSTAVE (0)
- The A3 adenosine receptor has a crucial role in determining blood pressure and matrix deposition in the vasculature: Studies in knock out mice (2000) (0)
- Angiotensin inhibitors for hypertension. (1980) (0)
- The year in hypertension (2004) (0)
- Hypertension in the elderly: pathophysiology of aging of the cardiovascular system (1993) (0)
- ANTIHYPERTENSIVE ACTION OF P-ADRENOCEPTOR BLOCKADE AND THE RENIN-ANGIOTENSIN SYSTEM (2006) (0)
- UPREGULATION OF GENE EXPRESSION OF BRADYKININ RECEPTORS TYPE 1 AND 2 IN PERIPHERAL MONOCYTES IN PATIENTS WITH ESSENTIAL HYPERTENSION: PP.20.148 (2011) (0)
- Angiotensin-converting enzyme inhibitors or calcium channel blockers? An overview. (1990) (0)
- CHOLESTEROL ENRICHED DIET IS A RISK FACTOR FOR ARTERIAL RIGIDITY AND WORSENED RENOVASCULAR HYPERTENSION IN RATS: P3.168 (2000) (0)
- Role of the Bradykinin B 2 Receptor in Salt-Induced Hypertension (2000) (0)
- Clinical management of hypertension in the elderly. (1987) (0)
- Clinical application of orally active angiotensin converting enzyme inhibitors. (1983) (0)
- SystemInhibition inAcute Myocardial Infarction inDogs Effects on Systemic Hemodynamics, Myocardial BloodFlow, Segmental Myocardial Function andInfarct Size (1982) (0)
- [International experience with the use of lisinopril in arterial hypertension]. (1990) (0)
- Inotropic and chronotropic effects of insulin in the conscious dog: Contribution of catecholamines and hypoglycemia (1981) (0)
- OR-47: Effect of rapid blood pressure decreases on coronary flow reserve in normal coronary arteries (2003) (0)
- [Clinical management of hypertension in the elderly]. (1987) (0)
- Plasma Endothelin of Sibpairs: Variability, Inheritance, and Linkage to Obesity in Essential Hypertension (2000) (0)
- Localization of a gene for blood pressure regulation to human chromosome 18q (1998) (0)
- Role of the Bradykinin B2 Receptor in Salt-Induced Hypertension (2000) (0)
- New Developments in the Field of RAS Inhibition (2010) (0)
- Abstract 231: An Angiotensin II Type I Receptor Mutant Ameliorates The Hypertension And Cardiac Hypertrophy Caused By Chronic Angiotensin II Infusion In Transgenic Mice (2008) (0)
- OR 42: Novel role for podocin as a genetic cause of hypertension (2004) (0)
- P-348: Reversal of salt-induced hypertension by translational inhibition of the alpha2B-adrenergic receptor (AR) (2002) (0)
- Use of Saralasin as a Diagnostic Test in Hypertension: Report of a Consensus Committee (1983) (0)
- Early experience with quinapril in the management of hypertension (1992) (0)
- Chapter 35 – ACE Inhibitor Trials: Effects in Hypertension (2005) (0)
- Letters to the Editor (1988) (0)
- ACE inhibitors and myocardial infarction (1993) (0)
- [Long-term minoxidil therapy: renin, aldosterone, noradrenaline and the need for beta blockers]. (1978) (0)
- Cardioprotective potential of angiotensin‐converting enzyme inhibitors (1991) (0)
- Vascular Medicine A 2 b Adenosine Receptor Regulates Hyperlipidemia and Atherosclerosis (2012) (0)
- Management of Health Care Workers With Blood-Borne Infections (2017) (0)
- D043: Efficacy of eprosartan in patients with essential hypertension: A 26-week comparison study of eprosartan versus enalapril (1998) (0)
- The Role of Double Renin-Angiotensin System Blockade (2008) (0)
- Blood Pressure Response to Central and/or Peripheral Inhibition of Phenylethanolamine iV-Methyltransferase in Normotensive and Hypertensive Rats (2005) (0)
- Therapeutic Advances: Hypertension in the Elderly (2010) (0)
- Abstract P109: A Promising Novel Hypertension Drug Candidate (2021) (0)
- Role of the renin angiotensin system and the sympathetic nervous system in the heart (1998) (0)
- Angiotensin Converting EnzymeInhibition inPatients withCongestive HeartFailure (1978) (0)
- Commentary on Kostis' report from SOLVD. (1996) (0)
- [Renin and sodium and the formation of vascular lesions in hypertension]. (1974) (0)
- ENALAPRIL IN MILD TO MODERATE HYPERTENSION (1990) (0)
- Result of the U.S. hypertension report card (1997) (0)
- The position of beta-blockers in antihypertensive therapy. Comparison with other antihypertensive agents. (1979) (0)
- Stimulation of vasopressin by calcium microinjections in the area of the paraventricular nucleus of the hypothalamus (1987) (0)
- Traitement chronique de l'hypertension arterielle par un inhibiteur de l'enzyme de conversion de l'angiotensine. [Chronic treatment of hypertension by an inhibitor of angiotensin converting enzyme] (1978) (0)
- Angiotensin II and renal failure. (1971) (0)
- Commentary 1 (2012) (0)
- UPREGULATION OF BRADYKININ RECEPTORS 1 AND 2 GENE TRANSCRIPT LEVELS IN PERIPHERAL MONOCYTES IN PATIENTS WITH ESSENTIAL HYPERTENSION (2011) (0)
- Principal Discussant (2005) (0)
- WHAT DATA ARE REQUIRED TO ADOPT NEW ANTIHYPERTENSIVE AGENTS? (1996) (0)
- Fixed Combinations in Antihypertensive Therapy (2008) (0)
- Mouse models of experimental hypertension (1997) (0)
- Role of Vasopressinin ClinicalHypertensionand CongestiveCardiac Failure: Interactionwith the SympatheticNervousSystem (1991) (0)
- Letters to the Editor Effect of Sodium on Central a 2 -adrenergic Receptors (0)
- Wednesday, 29 August 2012 (2012) (0)
- Cloning and expression of a rat brain a 2 B-adrenergic receptor ( a 2-adrenergic receptor subtypes / cDNA / [ 3 H ] rauwolscine / antisense mRNA ) (0)
- The Use of SQ 20,881 Converting Enzyme Inhibitor (Teprotide) for Diagnostic Purposes in Hypertension (1980) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Haralambos P. Gavras?
Haralambos P. Gavras is affiliated with the following schools:
